Ocugen initiates dosing in Phase 1/2 trial for retinitis pigmentosa candidate
April 01 2022 - 8:04AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ocugen (NASDAQ:OCGN)
Historical Stock Chart
From Apr 2023 to Apr 2024